SUNITINIB PLIVA
Capsule, hard, 25 mg
RestrictedActive license
Active substance (INN)
sunitinib
Pharmaceutical form
Pharmaceutical formCapsule, hard
Strength25 mg
PackagingUkupno 28 kapsula tvrdih u blisteru djeljivom na pojedinačne doze (4x7) u kartonskoj kutiji
ManufacturerTeva Operations Poland Sp. z o.o., Poland
Therapeutic groupAntineoplastic and immunomodulating agents (L01EX01)
Marketing authorization holder"EVROPA LEK PHARMA" DOO PODGORICA
Authorization dateFebruary 13, 2023
Analogs in Montenegro
20Other medicines with the same active substance
FASINDORRestricted
Capsule, hard, 50mgFASINDORRx
Capsule, hard, 12.5mgFASINDORRx
Capsule, hard, 25mgMISVENOLRx
Capsule, hard, 25mgMISVENOLRx
Capsule, hard, 50mgMISVENOLRx
Capsule, hard, 12.5mgSUNITINIB PLIVARestricted
Capsule, hard, 50 mgSUNITINIB PLIVARestricted
Capsule, hard, 12.5 mgSUNITINIB SANDOZRx
Capsule, hard, 12.5mgSUNITINIB SANDOZRx
Capsule, hard, 25mgSUNITINIB SANDOZRx
Capsule, hard, 50mgSUNITINIB ZENTIVARx
Capsule, hard, 25mgSUNITINIB ZENTIVARx
Capsule, hard, 50mgSUNITINIB ZENTIVARx
Capsule, hard, 12.5mgSUNITINIB ZENTIVARx
Capsule, hard, 25mgSUNITINIB ZENTIVARx
Capsule, hard, 50mgSUNITINIB ZENTIVARx
Capsule, hard, 12.5mgSUTENTRx
Capsule, hard, 25mgSUTENTRx
Capsule, hard, 50mgSUTENTRx
Capsule, hard, 12.5mgSource: CInMED register